The translabyrinthine approach is a surgical technique used to access tumours located near the inner ear and the cerebellopontine angle, a region close to the brainstem. In this procedure, surgeons reach the tumour by passing through the inner ear structures (labyrinth), which results in the loss of hearing on the operated side but allows safe and direct access to the affected area.
This approach is commonly used for removing vestibular schwannomas (acoustic neuromas) and other skull base tumours when hearing preservation is not possible. The translabyrinthine technique offers surgeons a clear view of critical structures such as the facial nerve, helping reduce the risk of nerve injury and postoperative complications.
Many people believe that skull base surgeries are always highly invasive. However, the translabyrinthine approach is designed to provide precise tumour removal with minimal brain retraction, improving surgical safety and patient recovery.
Understanding this procedure, its advantages, and recovery expectations helps patients and families make informed decisions. With advanced imaging, microsurgical tools, and continuous nerve monitoring, the translabyrinthine approach has become a reliable method for achieving good tumour control, facial nerve preservation, and overall treatment success.Doctors choose the surgical approach based on tumour size, location, hearing status, and overall patient condition.
People may need the translabyrinthine skull base approach when they have tumours located near the inner ear and cerebellopontine angle, such as vestibular schwannomas (acoustic neuromas), that have already caused significant hearing loss. This approach allows surgeons to access and remove the tumour safely without disturbing critical brain structures.
The translabyrinthine approach helps in achieving complete tumour removal. Although hearing on the operated side is lost, the procedure offers excellent visibility for surgeons, reducing risks and improving overall neurological outcomes and quality of life.
The translabyrinthine skull base approach is not a disease itself but a surgical method used to treat tumours or lesions located near the inner ear and cerebellopontine angle. Common causes of these conditions include:
Symptoms depend on the size, type, and location of the tumour near the inner ear and brainstem. Common signs include:
Surgery using the translabyrinthine approach is recommended when tumours in the inner ear or cerebellopontine angle grow larger, cause complete hearing loss, or start pressing on the facial nerve or brainstem. Early surgical intervention helps prevent further nerve damage, relieve pressure on nearby structures, and achieve safe tumour removal while preserving facial nerve function.
A detailed diagnosis is essential before deciding on skull base surgery. Doctors may suggest:
Early diagnosis and timely treatment planning help reduce complications and protect vital nerve functions. If you or your loved one experiences one-sided hearing loss, tinnitus, or facial weakness, myheco can connect you with skilled neurosurgeons at top skull base surgery centres for expert guidance and care.
Several hospitals worldwide offer specialised care for patients needing the translabyrinthine skull base approach. These centres are equipped with state-of-the-art neurosurgical and otologic facilities, ensuring precision and safety in complex skull base procedures. The focus is on complete tumour removal, facial nerve preservation, and optimal recovery outcomes.
Leading hospitals for translabyrinthine approach surgery include:
.png)
.png)
.png)
.png)
These hospitals follow international guidelines for care and are equipped to support patients from various countries, from diagnosis and treatment to follow-up care after returning home.
The average cost of translabyrinthine approach surgery ranges from $4,600 to $8,300 in India and from $10,100 to $18,000 in Thailand. The total cost varies depending on factors such as tumour size, surgical complexity, hospital infrastructure, and individual patient needs. Before reviewing the detailed table of treatment-wise costs, it’s essential to understand the main factors that influence translabyrinthine surgery expenses.
Note: India has become a preferred destination for advanced treatment, offering world-class care at a fraction of the international cost. Patients benefit from expert doctors, modern medical technology, and affordable access to high-quality generic medicines, making treatment both effective and economical.
Note: Thailand has established itself as a premium destination, offering world-class hospitals, advanced technology, and internationally trained specialists. Patients choose Thailand not only for its high-quality medical care but also for its holistic approach, combining clinical excellence with exceptional comfort and service standards.
The above figures are approximate and can vary based on the hospital, location, and individual patient requirements. Always consult the healthcare provider for the most accurate and up-to-date pricing.
The currency conversion rates in the table above are based on data from March 2026.
Actual treatment costs may vary depending on tumour complexity, treatment plan, hospital policies, and length of stay. The listed figures are approximate estimates.
For a detailed cost estimate and guidance on treatment options, patients can contact myheco to connect with leading hospitals.
Translabyrinthine surgery is an effective treatment for vestibular schwannomas. In a study of 596 patients published on PubMed Central (PMC), complete tumour removal was achieved in 32% of cases and near-total removal in 58% of cases.
Tumour recurrence occurred in 5.5% (33 out of 596) of patients. Good facial nerve function after surgery was seen in 85% of patients, meaning most people retained normal or near-normal facial movement.
Leading hospitals follow a multidisciplinary, patient-focused approach for translabyrinthine procedures, combining accurate diagnosis, advanced microsurgical techniques, and comprehensive postoperative care. Their approach includes:
This integrated strategy ensures safe tumour removal, preserves facial nerve function, and provides optimal recovery and quality of life for patients undergoing translabyrinthine surgery.
From connecting patients with top specialists to arranging online consultations and personalised treatment plans, myheco ensures a seamless and well-coordinated medical journey. With guidance on travel, hospital selection, and post-treatment care, patients can focus on recovery while myheco manages all logistics and support.
Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.
Note: Myheco does not provide medical advice.
✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements
Patients with tumours near the inner ear and cerebellopontine angle, such as vestibular schwannomas, who have significant or complete hearing loss on the affected side, may be suitable. Your neurosurgeon will assess tumour size, location, and overall health before recommending this approach.
Potential risks include facial nerve weakness, balance issues, CSF leaks, bleeding, and infection. Hearing on the operated side is typically lost due to the surgical route. Careful planning and intraoperative nerve monitoring help minimise complications.
Hospital stay usually ranges from 5 to 10 days, depending on tumour size and complexity. Full recovery, including balance rehabilitation and facial nerve physiotherapy, may take several weeks to a few months.
Surgeons use continuous facial nerve monitoring during the procedure to protect nerve function. Most patients retain normal facial movements, though temporary or, rarely, permanent weakness may occur depending on tumour characteristics. Doctors assess tumour size, location, and nerve involvement to estimate the chances of facial nerve preservation.
Yes. Depending on tumour type and extent, surgery may be followed by stereotactic radiosurgery, targeted therapy, or other interventions to reduce the risk of recurrence. Doctors decide whether additional treatment is required based on surgical findings and follow-up scans.
Myheco connects patients with experienced specialists, arranges online consultations, helps with travel and visa logistics, ensures cost transparency, and supports patients at every stage, from preoperative planning to postoperative care and rehabilitation.
India’s leading hospitals for Translabyrinthine Surgery and advanced skull base procedures include Manipal Hospital, Apollo Hospital, and Fortis Hospital in Bangalore; Max Hospital, BLK-Max Super Speciality Hospital, Manipal Hospital Dwarka, Medanta – The Medicity, IBS (Institute of Brain and Spine), Apollo Indraprastha Hospital, and Fortis Hospital in Delhi; Nanavati Max Super Speciality Hospital, Apollo Hospital, and Fortis Hospital in Mumbai; Apollo Proton Cancer Centre (APCC), Apollo Hospital, SIMS Hospital, MGM Healthcare, and Rela Hospital in Chennai; and Apollo Hospital in Hyderabad. These centres are recognised for specialised lateral skull base surgery programs, neurotology expertise, intraoperative facial nerve monitoring, and multidisciplinary ENT-neurosurgery collaboration for safe tumour removal.
In Thailand, Samitivej Sukhumvit Hospital in Bangkok is internationally recognised for advanced translabyrinthine skull base surgery, microsurgical techniques, and continuous facial nerve monitoring. The hospital also provides dedicated international patient support services for patients travelling for treatment.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - www.myheco.com
.png)